A must read on Glaxo Smith Kline's marketing of Avandia to the African-American community. The congressional hearing concerning the diabetes drug is set for today. GSK has updated their site to include a video addressing the safety concerns as well. Meanwhile, the Food and Drug Administration's formation of an advisory committee on risk communications is not, repeat not, a response to the Avandia crisis. Still, good timing.
Have you registered with us yet?
Register now to enjoy more articles and free email bulletins